CM
MRTX

Crystalline Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Crystalline Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-10,000
Closed -$361K – 133
2023
Q2 		$361K Hold
10,000
– – 0.26% 69
2023
Q1 		$534K Hold
10,000
– – 0.39% 49
2022
Q4 		$453K Buy
+10,000
New +$453K 0.23% 76